About
Abbratech develops a platform technology for discovering, engineering, and validating recombinant antibodies targeting human disease proteins that are difficult to access by conventional methods.
Explore Abbratech Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.